Basket | Login | Register


VIVIAD (coming soon)

Phase II trials

Study Information

Name of the study

A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD

Study sponsor

Vivoryon Therapeutics AG


Mild cognitive impairment and mild Alzheimer’s disease


Phase II

Information about the drug that will be tested in the studies

Name of the drug


Where and when will the study be conducted?

European countries involved in the trial (active)

  • Denmark
  • Germany
  • The Netherlands

Information for your doctor identifier


Link to full text



Last Updated: Wednesday 11 November 2020